European Medicines Agency (EMA) approved Moderna’s COVID-19 vaccine for children aged 12 to 17 years on Friday.
The drug regulator of European Union (EU) informed that a study conducted among 3,732 children aged 12 to 17 years found that a comparable antibody response was seen in young adults aged 18 to 25 years vis-à-vis the effects of Spikevax vaccine.
None of the 2,163 children who were injected the Spikevax vaccine got infected with COVID-19 compared with four out of 1,073 children administered placebo. The conclusion was that efficacy of Moderna’s vaccine in those aged 12 to 17 is similar to that in adults.
The common side-effects of Spikevax vaccine in children were same as those in adults — pain and swelling at the injection site, headache, nausea, vomiting and fever.
There will be two jabs of Spikevax vaccine in the muscles of upper arm, four weeks apart.
Lahore: It will be India and New Zealand to face off in the Champions Trophy… Read More
Bhubaneswar: Coffee Board Chairman M J Dinesh met Odisha’s Deputy Chief Minister Kanak Vardhan Singh… Read More
Bhubaneswar: Odisha capital will soon have air connectivity with two more domestic destinations - Ghaziabad… Read More
New Delhi: Taking a trip down memory lane, actress Parineeti Chopra said in a recent… Read More
New Delhi: Mani Shankar Aiyar is known to speak his mind without caring about political… Read More
Hyderabad: ‘Jawan’ actress Nayanthara took to social media to request fans to stop calling her… Read More
This website uses cookies.
